IPO Premiums
IPO calendar
JLJLHLListed

Jupiter Life Line Hospitals Limited

Book Built Issue IPO · NSE, BSE

Price band
₹695 - ₹735
Lot size
20 shares
Issue amount
₹869.08 cr
Total subscription
63.72×
Current price₹243.9
Listing price ₹973
Watch live price ↗
Opens
6 Sept 2023
Closes
8 Sept 2023
Allotment
13 Sept 2023
Listing
18 Sept 2023

Offer at a glance

Issue overview

Issue size
1,18,24,163 shares
Face value
₹10 per share
Minimum investment
₹13,900
Fresh issue
₹542 cr
Offer for sale
₹327.08 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,700
Issue type
Book Built Issue IPO
Shares before issue
5,81,91,859
Shares after issue
0

Lot sizes

CategoryLotsSharesAmount
RETAIL120₹14,700
sHNI14280₹2,05,800
bHNI691,380₹10,14,300

Share reservation

Retail36.26%
NII(HNI)15.54%
QIB20.07%

Subscription & GMP

Subscription by category

Total subscribed63.72×

Missing multiples are calculated from bids and offered shares when available.

QIB187.32×
NIB34.75×
HNIs(10L +)39.24×
HNIs (2-10L)25.78×
RETAIL7.73×

GMP history

012324618 Mar: ₹246
18 Mar₹24618 Mar

Application-wise demand

CategoryReserved applicationsApplied applications
——

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs174.4132,670.37
RETAIL315.092,434.25
NIB135.044,692.7
HNIs 2+45.011,160.45
HNIs 10+90.033,532.25

Financial performance

Company financials

in ₹ Crore · Reported periods may include interim results.

Revenue & profitin ₹ Crore
-50005001,000Mar 2023 · Revenue: 902.96Mar 2023 · Profit after tax: 72.91Mar 2023Mar 2022 · Revenue: 737.14Mar 2022 · Profit after tax: 51.13Mar 2022 Mar 2021 · Revenue: 490.27Mar 2021 · Profit after tax: -2.3Mar 2021
RevenueProfit after tax

Key performance indicators

MetricValues
EPS13.95
ROE20.03
ROCE20.94
RONW20.03
PRE IPO(PE)52.68
POST IPO(PE)66.1

Values and labels as reported in the issue data.

Company information

Company profile

Founded in 2007, Jupiter Life Line Hospitals Limited is a leading multi-specialty healthcare provider in the Mumbai Metropolitan Region (MMR) and western India. Operating under the "Jupiter" brand, the company runs three hospitals in Thane, Pune, and Indore, with a total of 1,194 beds and a team of 1,306 doctors, including specialists, physicians, and surgeons (as of March 31, 2023). A new multi-specialty hospital is also under development in Dombivli, Maharashtra, with plans for over 500 beds. Construction began in April 2023. Jupiter Life Line Hospitals stands out for its advanced neuro-rehabilitation services in Thane and Indore, featuring robotic and computer-assisted treatments, as highlighted in the CRISIL Report. It also operates one of the few multi-organ transplant centers in Thane. All its hospitals are NABH-certified and NABL-accredited for medical testing. In Fiscal 2023, revenue from inpatient and outpatient services was distributed across its hospitals: Thane (54.18%), Pune (34.03%), and Indore (11.79%).

Promoters

Dr. Ajay Thakker

Dr. Ankit Thakker

Western Medical Solutions LLP

Read the latest IPO market update.

Registrar & documents

Lead manager

ICICI Securities Limited, Nuvama Wealth Management Limited, Jm Financial Limited

Registered office

1004, 10th Floor, 360 Degree Business Park, Maharana Pratap Chowk, LBS Marg, Mulund (West), Mumbai – 400 080

+ 91 22 2172 5623

[email protected]Company website ↗

Understanding JLHL IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.